- Home
- BMRN vs FRHC Comparison
BMRN vs FRHC Comparison
Compare BMRN & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | FRHC |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 8.7B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | FRHC |
|---|---|---|
| Price | $53.19 | $133.21 |
| Analyst Decision | Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $88.42 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 90.9K |
| Earning Date | 10-27-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | 0.08 |
| Revenue | ★ $3,094,001,000.00 | $1,563,510,000.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $7.57 | N/A |
| P/E Ratio | ★ $19.92 | $1,722.97 |
| Revenue Growth | 12.39 | ★ 16.04 |
| 52 Week Low | $50.76 | $111.85 |
| 52 Week High | $73.51 | $194.01 |
Technical Indicators
Market Signals| Indicator | BMRN | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 38.02 |
| Support Level | $53.03 | $131.00 |
| Resistance Level | $54.66 | $138.27 |
| Average True Range (ATR) | 1.45 | 4.52 |
| MACD | -0.11 | 0.91 |
| Stochastic Oscillator | 31.61 | 20.28 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.